Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer is a research paper published in Cancers (2020). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
European Research Council
Grant: ERC-2016-STG-716220
National Institutes of Health
Grant: U01GM120419
UC Davis – Israel Collaborations in Research
Grant: 2019
European Research Council
Grant: 716220
Selective glycoimmuno-targeting for cancer therapy
National Institutes of Health
Grant: 5U01GM120419-04
Facile chemoenzymatic synthesis and purification of glycolipids
FWCI
1.05
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals